Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) just unveiled an announcement.
EBR Systems, Inc. announced the first patient enrolment and implant in the Totally Leadless CRT (TLC-AU) study, marking a significant milestone in the development of its WiSE System as a first-line therapy for heart failure patients. This study, conducted in Australia, aims to evaluate the feasibility of using the WiSE System with a leadless pacemaker to provide a totally leadless CRT solution, potentially expanding EBR’s addressable market and reinforcing its leadership in heart-failure treatment.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Silicon Valley-based EBR Systems, Inc. is focused on enhancing cardiac rhythm disease treatment through its innovative wireless cardiac pacing technology, WiSE. This technology aims to eliminate complications associated with traditional cardiac pacing leads by providing wireless stimulation to the heart’s left ventricle, potentially offering a more effective and reliable solution for heart failure patients requiring Cardiac Resynchronisation Therapy (CRT).
Average Trading Volume: 700,680
Technical Sentiment Signal: Sell
Current Market Cap: A$413.9M
For a thorough assessment of EBR stock, go to TipRanks’ Stock Analysis page.